Skip to content
Screener

Upstream Bio, Inc. UPB Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$12.04M-13.5%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$983.41K+36.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$2.23M+89.2%
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
6.4%+1.7pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$41.1M-10.7%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$7.71M-33.0%

Other financials

Income statement

See full
Revenue$773.0K-17.5%
Operating income-$42.4M+4.5%
Net income-$39.7M+0.7%
EPS (diluted)-$0.73+1.4%

Balance sheet

See full
Cash & equivalents$79.4M+74.7%
Total debt$954.0K-38.9%
Total equity$271.0M-33.7%
Total assets$281.2M-33.1%

Cash flow

See full
Operating cash flow-$35.6M+9.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$404.88M-54.7%
Enterprise value$326.44M-61.6%
P/S128.2×-200×

Profitability

See full
Operating margin-5,382.6%+1,393pp
Net margin-4,955.7%+2,041pp

Returns & leverage

See full
Return on equity-46%
Debt / equity0.0×
Current ratio28×-10.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 7:10 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-343417
Line itemJune 30, 2026December 31, 2025
Prepaid expenses and other current assets17,5239,620
Total current assets279,602351,797
Property and equipment, net460559
Operating lease right-of-use assets9151,222
Restricted cash194194
Total assets$281,171$353,772
Liabilities and Stockholders’ Equity
Current liabilities:

Item 1. Financial Statements.

FAQ

What is Upstream Bio, Inc.'s operating lease ROU assets?
Upstream Bio, Inc. (UPB) reported operating lease ROU assets of $915K in Q2 2026.
How has Upstream Bio, Inc.'s operating lease ROU assets changed year-over-year?
Upstream Bio, Inc.'s operating lease ROU assets decreased by 39.4% year-over-year, from $1.51M to $915K.
What is the long-term trend for Upstream Bio, Inc.'s operating lease ROU assets?
Over 2 years (2023 to 2025), Upstream Bio, Inc.'s operating lease ROU assets has grown at a 433.1% compound annual growth rate (CAGR), from $43K to $1.22M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Upstream Bio, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude